C4 Therapeutics Inc
(CCCC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,434 | 0 | 0 | N/A | 0 |
| Marketable Securities | 135,979 | 0 | 0 | N/A | 0 |
| Receivables | 4,141 | 0 | 0 | N/A | 0 |
| TOTAL | $208,924 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 3,580 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 16,623 | 0 | 0 | 0 | 0 |
| TOTAL | $20,203 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $229,127 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,264 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 9,830 | 0 | 0 | N/A | 0 |
| TOTAL | $40,009 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,877 | 0 | 0 | N/A | 0 |
| Deferred Revenues | 23,915 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 17,562 | 0 | 0 | 0 | 0 |
| TOTAL | $88,522 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $128,531 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,030 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | 0 | N/A | 0 |
| Retained earnings | -162,028 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 256,528 | 0 | 0 | 0 | 0 |
| TOTAL | $100,596 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $229,127 | $0 | $0 | $0 | $0 |